Get the Stockscreener App
12.75
0.71%
0.09
After Hours:
12.73
-0.02
-0.16%
Galecto Inc stock is traded at $12.75, with a volume of 161.45K.
It is up +0.71% in the last 24 hours and up +344.25% over the past month.
Galecto Inc is a clinical-stage biotechnology company developing therapeutics designed to target the biological processes that lie at the heart of cancer and liver diseases. Its initial focus is on the development of small-molecule inhibitors of galectin-3 and lysyl oxidase-like 2, or LOXL2. Its product candidate GB0139 is for the treatment of severe fibrotic lung diseases such as idiopathic pulmonary fibrosis, or IPF, a life-threatening progressive fibrotic disease of the lung. Its product GB1211, a selective oral galectin-3 inhibitor for the treatment of fibrosis related to non-alcoholic steatohepatitis, or NASH, and GB2064, a selective oral inhibitor of LOXL2 that it initially plans to develop for the treatment of myelofibrosis.
See More
Previous Close:
$12.66
Open:
$12.78
24h Volume:
161.45K
Relative Volume:
0.07
Market Cap:
$16.89M
Revenue:
-
Net Income/Loss:
$-38.35M
P/E Ratio:
-8.7931
EPS:
-1.45
Net Cash Flow:
$-36.91M
1W Performance:
+243.67%
1M Performance:
+344.25%
6M Performance:
+449.57%
1Y Performance:
+75.38%
1-Day Range:
$12.41
$13.06
1-Week Range:
$9.8812
$31.70
52-Week Range:
$2.01
$31.70
Galecto Inc Stock (GLTO) Company Profile
Name
Galecto Inc
Sector
Industry
Phone
45-70-70-52-10
Address
75 STATE STREET, BOSTON
Compare GLTO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GLTO
Galecto Inc
|
12.75 | 16.77M | 0 | -38.35M | -36.91M | -1.45 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Galecto Inc Stock (GLTO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-26-21 | Resumed | Credit Suisse | Outperform |
| Nov-23-20 | Initiated | BofA Securities | Buy |
| Nov-23-20 | Initiated | Credit Suisse | Outperform |
| Nov-23-20 | Initiated | SVB Leerink | Outperform |
Galecto Inc Stock (GLTO) Latest News
Best Biotech Stocks To ConsiderOctober 9th - MarketBeat
Can Galecto Inc. stock hit analyst price targets2025 Market Sentiment & Fast Moving Stock Trade Plans - newser.com
How to monitor Galecto Inc. with trend dashboardsWeekly Gains Report & Weekly Setup with High ROI Potential - newser.com
Understanding Galecto Inc.’s price movementJuly 2025 Price Swings & Short-Term Swing Trade Alerts - newser.com
Micron, Galecto And Xenetic Lead This Week's Benzinga Stock Ranking Surges - Benzinga
Visual analytics tools that track Galecto Inc. performanceDip Buying & Fast Gain Stock Tips - newser.com
Market reaction to Galecto Inc.’s recent newsQuarterly Performance Summary & AI Powered Buy and Sell Recommendations - newser.com
Published on: 2025-10-10 09:33:55 - newser.com
Galecto Inc. stock chart pattern explained2025 Year in Review & Real-Time Stock Price Movement Reports - newser.com
Does Galecto Inc. qualify in momentum factor screeningWeekly Trade Analysis & Low Drawdown Momentum Ideas - newser.com
Technical signs of recovery in Galecto Inc.M&A Rumor & Growth Oriented Trade Recommendations - newser.com
Is Galecto Inc. trending in predictive chart modelsJuly 2025 Reactions & Consistent Income Trade Recommendations - newser.com
What candlestick patterns are forming on Galecto Inc.July 2025 Sector Moves & Free Safe Capital Growth Stock Tips - newser.com
What Fibonacci levels say about Galecto Inc. rebound2025 Volatility Report & Stock Portfolio Risk Control - newser.com
Analyzing net buyer seller activity in Galecto Inc.Global Markets & Community Shared Stock Ideas - newser.com
Nasdaq and NYSE’s biggest gainers and losers in Thursday’s premarket - MSN
What recovery options are there for Galecto Inc.Earnings Overview Summary & AI Driven Price Predictions - newser.com
Tick level data insight on Galecto Inc. volatilityJuly 2025 Patterns & Consistent Profit Alerts - newser.com
Is Galecto Inc. stock reversal real or fake2025 Market Overview & Verified Swing Trading Watchlists - newser.com
Ranking Galecto Inc. among high performing stocks via toolsQuarterly Profit Review & Entry Point Confirmation Signals - newser.com
Analyzing recovery setups for Galecto Inc. investorsJuly 2025 Final Week & Growth-Oriented Investment Plans - newser.com
Small Cap Stocks To Consider – October 7th - Defense World
Top movers on Nasdaq and NYSE in Wednesday’s premarket session - MSN
Galecto (GLTO) Stock: Biotech Surges 600% in Wild Retail Trading Frenzy - parameter.io
Nasdaq Gains 150 Points; US Mortgage Applications Decline - Benzinga
Morning Market Movers: XBIO, UPC, GLTO Spark Big Moves - RTTNews
U.S. stock futures today: Dow, S&P 500, Nasdaq flat amid AI bubble fears as gold surges past $4,000 — chec - The Economic Times
Why Confluent Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket - Benzinga
POET Technologies, Oracle, Nuburu, Galecto And TMC The Metals Company: Why These 5 Stocks Are On Investors' Radars Today - NewsBreak: Local News & Alerts
POET, ORCL, BURU, GLTO, TMC: 5 Trending Stocks TodayGalecto (NASDAQ:GLTO), Nuburu (AMEX:BURU) - Benzinga
This Penny Stock Just Jumped 750%. Can It Retain These Gains for the Long Term? - Yahoo Finance
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.20% - Investing.com
United States shares lower at close of trade; Dow Jones Industrial Average down 0.20% - Investing.com India
GLTO Stock Rises A Whopping 632% Pre-Market, But Retail Investors Remain Cautious - Stocktwits
What's Going On With Nano-Cap Galecto Stock On Tuesday? - Benzinga
GLTO stock explodes 632% but investors smell trouble - Rolling Out
Dow Jumps Over 100 Points; McCormick Earnings Top Views - Benzinga
Bitcoin Becomes New ‘Hurdle Rate’ As Investors Chase BTC Gains, Says Anthony Pompliano - Stocktwits
Galecto Stock Skyrockets 600% – Short Squeeze Mania or Biotech Breakthrough? - ts2.tech
Is Archrock (AROC) Undervalued? A Fresh Look at the Company's Fair Value and Investor Expectations - Yahoo Finance
Humacyte Announces Pricing of $60.0 Million Oversubscribed Registered Direct Offering - Yahoo Finance
PayPal Stock Rallies After Company Announces Ads Manager For Small Businesses With No Upfront Costs - Stocktwits
Zacks.com featured highlights include Arista Networks, TE Connectivity, Corning, Banco Bilbao Vizcaya Argentaria and AppLovin - Yahoo Finance
White House doubles down on Alaska mining, buys 10% of Trilogy Metals - Yahoo Finance
Morning Market Movers: GLTO, CISS, SPRB, LXEO See Big Swings - RTTNews
Kentucky Governor Grapples With Tariffs, Says 2028 Call Can Wait - Yahoo Finance
Why Telomir Pharmaceuticals Shares Are Trading Higher By 31%; Here Are 20 Stocks Moving Premarket - Benzinga
Real time breakdown of Galecto Inc. stock performanceTrade Volume Report & Daily Oversold Stock Bounce Ideas - newser.com
Long term hold vs stop loss in Galecto Inc.July 2025 Highlights & Daily Stock Trend Watchlist - newser.com
What drives Verrica Pharmaceuticals Inc 1NE stock priceDouble Top/Bottom Patterns & Superior Capital Trading Plans - earlytimes.in
Using data filters to optimize entry into Galecto Inc.Portfolio Gains Summary & Reliable Intraday Trade Alerts - newser.com
Galecto Inc Stock (GLTO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Galecto Inc Stock (GLTO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Winslow Garrett | General Counsel |
Jul 03 '25 |
Sale |
3.39 |
260 |
881 |
1,429 |
| Firmani Lori | Interim CFO |
Jul 03 '25 |
Sale |
3.39 |
147 |
498 |
692 |
| Winslow Garrett | General Counsel |
Jan 03 '25 |
Sale |
5.60 |
471 |
2,638 |
1,009 |
| Firmani Lori | Interim CFO |
Jan 03 '25 |
Sale |
5.63 |
261 |
1,469 |
465 |
| Schambye Hans T. | Chief Executive Officer |
Jan 03 '25 |
Sale |
5.60 |
1,341 |
7,510 |
3,397 |
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):